A mouth ulcer is a mucosal ulcer that involves sore or open lesion on mucous membrane inside the oral cavity. Generally, mouth ulcers do not require any specific treatment and they get healed within a span of 1015 days, without any treatment. Sometimes, mouth ulcers can be severe and requires immediate medical treatment for the reduction of liaison and pain severity. The Asia Pacific market for mouth ulcers treatment is growing significantly due to its high prevalence, low-cost treatment procedures, and improving healthcare systems. Rising aging population and increasing awareness are the additional drivers that are responsible for the growth of mouth ulcers treatment market in the recent years. However, the side effects that are associated with the treatment, particularly with steroid mouthwashes, are the major restraints for the market growth.
The Asia-Pacific mouth ulcers treatment market is segmented on the basis of type of therapeutics, formulation type, indications, and geography. Based on therapeutics, the market is segmented into corticosteroids, analgesics, antihistamines, anesthetics, and antimicrobials. Based on formulations, Asia-Pacific mouth ulcers treatment market is segmented into gels, mouthwash, lozenges, and sprays. Amongst them, the popularity of gels is notable due to its rising preference and ease of availability. In terms of therapeutic indications, the market is categorized as oral lichen planus, aphthous stomatitis and others. The prevalence of aphthous stomatitis is notably high in the overall population. The Asia Pacific mouth ulcers treatment market is segmented into China, Japan, India, Australia and others. Emerging economies in the Asia-Pacific region, such as India and China, are the potential markets due to a high prevalence of diseases and improving healthcare systems. Patients in large numbers across Asia-pacific suffer from aphthous stomatitis, which, presently, is indicating a huge potential for growth within this market.
KEY TAKE AWAYS
Widespread coverage of the Asia Pacific mouth ulcers treatment market including drivers, restraints, and opportunities would help professionals to better understand market behavior
The projections in this report are made by analyzing the current market trends and the market potential for the period 20132020, in terms of value
Comprehensive analysis of therapeutics, formulations type, indications, and geography segments enables the identification of growth opportunities within the Asia Pacific mouth ulcers treatment market
In-depth strategic study of key leaders within the Asia Pacific mouth ulcers treatment market would be informative for professionals in the corporate sector
Porters Five Forces framework examines the competitive structure of the Asia Pacific mouth ulcers treatment market and would be helpful for a strategic industry analysis
Ease of doing business analysis should help in making strategic business decisions
MOUTH ULCERS TREATMENT MARKET KEY SEGMENTS
The Asia-Pacific mouth ulcers treatment market is segmented into therapeutics, formulations type, indications, and geography segments.
BY THERAPEUTICS
Corticosteroid
Analgesic
Antihistamine
Anesthetic
Antimicrobial
BY FORMULATION TYPES
Gel
Mouthwash
Lozenge
Spray
BY INDICATION
Oral lichen planus
Aphthous stomatitis
Others
BY GEOGRAPHY
China
Japan
India
Australia
Others
Asia Pacific Mouth Ulcers Treatment Market Report Highlights
Aspects | Details |
By THERAPEUTICS |
|
By FORMULATION TYPES |
|
By INDICATION |
|
By Region |
|
Key Market Players | Reckitt Benckiser, Abbott, BLISTEX,, GlaxoSmithKline,, Colgate-Palmolive,, Bristol-Myers Squibb Company,, Pfizer,, Church & Dwight,, Taro Pharmaceutical Industries, 3M, |
Loading Table Of Content...